Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |